| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |